Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9

MeSH terms

• Androgen Antagonists / adverse effects*
• Diabetes Complications / therapy*
• Diabetes Mellitus / drug therapy*
• Exercise Therapy / methods*
• Fatigue / therapy*
• Gonadotropin-Releasing Hormone / adverse effects*
• Humans
• Male
• Myocardial Infarction / epidemiology*
• Myocardial Infarction / etiology*
• Orchiectomy / adverse effects*
• Physical Conditioning, Human / methods*
• Physical Conditioning, Human / physiology*
• Physical Fitness / physiology*
• Prostatic Neoplasms / complications*
• Prostatic Neoplasms / drug therapy*
• Prostatic Neoplasms / physiopathology*
• Prostatic Neoplasms / therapy*
• Quality of Life*
• Sedentary Behavior*
• Stroke / epidemiology*
• Stroke / etiology*